Trial intelligence / Profile preview

K-1728 in Advanced or Metastatic Solid Tumors

NCT07861932Phase 2Not yet recruiting

Start
Oct 2026
Primary completion
Sep 2028
01

Overview

A Phase 2 trial of K-1728 in solid tumor, breast neoplasms. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

K-1728
03

Conditions

solid tumorbreast neoplasms

Beyond the preview

Go deeper on NCT07861932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07861932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call